1 week ago
Hormel Foods Corp. (NYSE:HRL) agreed to sell its whole-bird turkey business as it reported preliminary fiscal first-quarter 2026 results on Tuesday, outlining a portfolio shift toward value-added protein products.
- HRL is showing weakness near its 52-week low. Check the latest price here.
The company announced its preliminary fiscal first-quarter results for 2026, projecting net sales of around $3 billion with a 2% organic net sales growth.
This announcement accompanies the company’s decision to sell its whole-bird turkey business to Life-Science Innovations (LSI), in line with Hormel’s focus on expanding value-added protein offerings.
Hormel’s Strategic Shift
Hormel’s divestment from its whole-bird turkey business is part of a broader strategy to strengthen its portfolio by emphasizing more stable, value-added products.
LSI is set to purchase Hormel Foods’ production and transportation assets in Minnesota, which include the Melrose whole-bird facility and the Swanville feed mill. The company will take over supply agreements with independent turkey growers and maintain co-manufacturing operations with ...
